---
$id: https://graph.org.ai/products/commodity/51112018
$type: Product
source: UNSPSC
code: "51112018"
title: "Vatalanib succinate"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vatalanib succinate

**UNSPSC Code**: 51112018
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular structure C20H15CLN4.C4H6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, V5FUB77031 chemically known as 1-phthalazinamine, n-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, butanedioate (1:1), but more commonly known as vatalanib succinate, which bears US NIH Compound Identifier 151193. European Medicines Agency schedules Vatalanib succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32570. As of Q4 2014, VATALANIB SUCCINATE remains US FDA's Preferred Term for this commodity. Vatalanib succinate bears US NLM identifiers UMLS ID C1524078 and NCI Concept Code C74945. Most nations, for tariff and trade purposes, schedule vatalanib succinate under HS 29333999 and SITC 51574. SMILES: C1CCC2C(C1)C(NNC2NC3CCC(CC3)CL)CC4CCNCC4.C(CC(=O)O)C(=O)O.

